Acquiring Company
EMS
Acquired Company
Medley
Description
Brazilian pharmaceutical giant EMS has reached a definitive agreement to acquire Medley, a generics unit from Sanofi, for approximately R$3.6 billion. The acquisition will enable EMS to secure a significant share of the Brazilian generic drug market and pave the way for its entry into the US market after 2030. The deal is pending approval from Brazil's antitrust authority. This move marks EMS's transition into an international player in the generics sector.
Who to call at EMS, and when
When EMS changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day EMS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EMS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EMS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EMS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Medley?
Medley was acquired by EMS, based in Illinois. The deal was reported on May 6, 2026. EMS is a value-added distributor of aluminum products. It operates as a portfolio company of Wynnchurch Capital, L.P. The company focuses on enhancing product offerings across various sectors. EMS is privately held and operates in Other.
When did EMS acquire Medley?
EMS's acquisition of Medley was reported on May 6, 2026. Brazilian pharmaceutical giant EMS has reached a definitive agreement to acquire Medley, a generics unit from Sanofi, for approximately R$3.6 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medley do?
Medley is a generics unit that was previously owned by the French healthcare company Sanofi. It is recognized for its contribution to the Brazilian pharmaceutical market, particularly in the generics sector. It is privately held, and is based in Brazil.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.